Polska Akademia Dostępności PAD CMS up to 1.2.1 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability identified as problematic has been detected in Polska Akademia Dostępności PAD CMS up to 1.2.1. Affected is an unknown function. Performing a manipulation results in cross site scripting. This vulnerability only affects products that are no longer supported by the maintainer. This vulnerability is identified as CVE-2025-8116. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability was found in Polska Akademia Dostępności PAD CMS up to 1.2.1. It has been classified as problematic. This affects some unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
PAD CMS is vulnerable to Reflected XSS in printing and save to PDF functionality. Malicious attacker can craft special URL, which will result in arbitrary JavaScript execution in victim's browser, when opened. This issue affects all 3 templates: www, bip and www+bip. This product is End-Of-Life and producent will not publish patches for this vulnerability.
The weakness was released by Jakub Szweda. It is possible to read the advisory at cert.pl. This vulnerability is uniquely identified as CVE-2025-8116 since 07/24/2025. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
Support
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/24/2025 CVE reserved09/30/2025 Advisory disclosed
09/30/2025 VulDB entry created
11/27/2025 VulDB entry last update
Sources
Advisory: cert.plResearcher: Jakub Szweda
Status: Confirmed
CVE: CVE-2025-8116 (🔒)
GCVE (CVE): GCVE-0-2025-8116
GCVE (VulDB): GCVE-100-326391
Entry
Created: 09/30/2025 14:22Updated: 11/27/2025 04:28
Changes: 09/30/2025 14:22 (67), 11/27/2025 04:28 (11)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.